Shaolin Capital Management LLC - PHOENIX BIOTECH ACQUISITION ownership

Back to all holdings Add to watchlist

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 15 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Shaolin Capital Management LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$543
-54.3%
50,000
-54.1%
0.02%
-51.3%
Q2 2023$1,187
+14.6%
108,877
+12.2%
0.04%
+25.8%
Q1 2023$1,036
+4.0%
97,0000.0%0.03%
+6.9%
Q4 2022$996
-99.9%
97,000
-2.3%
0.03%
+3.6%
Q3 2022$1,002,000–99,328–0.03%–
 Download
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q2 2023
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,178,3230.31%
METEORA CAPITAL, LLC 152,060$1,657,4540.30%
Mint Tower Capital Management B.V. 141,089$1,5380.15%
BERKLEY W R CORP 96,777$1,054,8690.06%
Shaolin Capital Management LLC 108,877$1,1870.04%
AQR Arbitrage LLC 79,873$862,6280.04%
FNY Investment Advisers, LLC 2,084$220.03%
Polar Asset Management Partners Inc. 120,000$1,288,8000.02%
CLEAR STREET LLC 191,100$2,0830.02%
Walleye Capital LLC 47,936$522,5020.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders